| 1 |
34359807 | Inhibitors Targeting CDK9 Show High Efficacy against Osimertinib and AMG510 Resistant Lung Adenocarcinoma Cells. | 2021 Aug 3 |
1 |
| 2 |
34771484 | Polycaprolactone Electrospun Scaffolds Produce an Enrichment of Lung Cancer Stem Cells in Sensitive and Resistant EGFRm Lung Adenocarcinoma. | 2021 Oct 22 |
2 |
| 3 |
31555510 | Hsp90 inhibitors enhance the antitumoral effect of osimertinib in parental and osimertinib-resistant non-small cell lung cancer cell lines. | 2019 Aug |
1 |
| 4 |
29641535 | Acquired resistance to AZD9291 as an upfront treatment is dependent on ERK signaling in a preclinical model. | 2018 |
4 |
| 5 |
25870145 | Acquired Resistance to the Mutant-Selective EGFR Inhibitor AZD9291 Is Associated with Increased Dependence on RAS Signaling in Preclinical Models. | 2015 Jun 15 |
1 |